Sign in

CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
841966887
Phone
(888) 378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 62 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-21 Warren Eric Chief Commercial Officer Option exercise 10b5-1 +7,438 $13.24 $98K 45,838
2026-09-21 Warren Eric Chief Commercial Officer Sale 10b5-1 −7,438 $28.12 $209K 38,400
2026-09-21 Warren Eric Chief Commercial Officer Option exercise · Stock Option 10b5-1 −7,438 230,563
2026-08-21 Warren Eric Chief Commercial Officer Option exercise 10b5-1 +7,437 $13.24 $98K 45,837
2026-08-21 Warren Eric Chief Commercial Officer Sale 10b5-1 −7,437 $25.98 $193K 38,400
2026-08-21 Warren Eric Chief Commercial Officer Option exercise · Stock Option 10b5-1 −7,437 238,001
2026-07-21 Warren Eric Chief Commercial Officer Option exercise 10b5-1 +7,438 $13.24 $98K 45,838
2026-07-21 Warren Eric Chief Commercial Officer Sale 10b5-1 −7,438 $26.87 $200K 38,400
2026-07-21 Warren Eric Chief Commercial Officer Option exercise · Stock Option 10b5-1 −7,438 245,438
2026-06-26 Warren Eric Chief Commercial Officer Option exercise 10b5-1 +104,124 $13.24 $1.4M 142,524
2026-06-26 Warren Eric Chief Commercial Officer Sale 10b5-1 −104,124 $25.90 $2.7M 38,400
2026-06-26 Warren Eric Chief Commercial Officer Option exercise · Stock Option 10b5-1 −104,124 252,876

Page 1 of 1 · 12 trades